Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase

Pyridazinone derivatives as novel c-Met inhibitors were designed and synthesized via a cyclization strategy. 19 was found with favorable pharmacokinetic properties and significant antitumor activity.167